Co-administration of JQ1, a bromodomain-containing protein 4 inhibitor, enhances the antitumor effect of combretastatin A4, a microtubule inhibitor, while attenuating its cardiotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-administration of JQ1, a bromodomain-containing protein 4 inhibitor, enhances the antitumor effect of combretastatin A4, a microtubule inhibitor, while attenuating its cardiotoxicity

Published:2023-04 Issue: Volume:160 Page:114353
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Orihara Haruka,Ma Min^ORCID,Nagashima Yoshiyasu,Tochinai Ryota,Sekizawa Shin-ichi,Kato Daiki,Shinada Masahiro,Aoki Susumu,Fujita Naoki,Nakagawa Takayuki,Tsuru Yoshiharu,Tatewaki Yasuko,Mutoh Tatsushi^ORCID,Taki Yasuyuki,Nishimura Ryohei,Kuwahara Masayoshi

Funder

Japan Society for the Promotion of Science

Tohoku University

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference41 articles.

1. Cardiovascular side-effects of modern cancer therapy;Minami;Circ. J.,2010

2. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

3. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004

4. Taxol found on tubulin;Makowski;Nature,1995

5. Combretastatin A-4 analogues as antimitotic antitumor agents;Nam;Curr. Med. Chem.,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti‐tumor and cardiotoxic effects of microtubule polymerization inhibitors: The mechanisms and management strategies;Journal of Applied Toxicology;2023-07-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP